Interleukin-37 (IL-37
Interleukin-37 (IL-37) possesses the function of down-regulate systemic and local inflammation. It is unknown whether IL-37 is expressed in human regulatory T cells (Tregs) and its role in modulating
It is now well accepted that regulatory T cells (Tregs) are crucial to the proper maintenance of immune self-tolerance and homeostasis 1, 2 . By drifting of helper T cell (Th)1/Th2 as a result of stimulation of T cell receptor signal, Tregs regulate immune system with immunosuppression 3, 4 . Not only showing marked influence on immunosuppression, Tregs also play a role in developing immune nonreactivity. The phenomenon manifests as nonreactivity to antigenic stimulation and an interference of interleukin (IL)-2 expression, even stimulated by high concentration of IL-2. Tregs should be stimulated and proliferated, however, the level of proliferation is obviously lower than that of CD4 +
CD25
− T cells. Tregs are different from other regulatory or suppressor cells by possessing particular immunological characteristics. Tregs can express different kinds of cell molecules. Some molecules promote the growth and liveness of cells, including Toll-like receptors (TLRs) as well as forkhead/winged helix transcription factor p3 (FOXP3), which identify pathogen associated molecule patterns or promote Treg function or proliferation. Tregs also persistently express some other factors including glucocorticoid-induced tumor necrosis factor (TNF) receptor (GITR) and intracellular cytotoxic T-lymphocyte-associated antigen (CTLA)-4. In addition, Tregs can produce various immunosuppressive cytokines, including transforming growth factor (TGF)-β and IL-10, and they might also contribute to the inhibition of effector T cells [5] [6] [7] [8] [9] [10] . IL-37, which is the seventh interleukin factor of interleukin 1 family (IL-1F7), has the ability to down-regulate systemic and local inflammation by lowering levels of pro-inflammatory mediators 11, 12 . Also, it is involved in both innate and adaptive immunity. With evidences accumulated, IL-37 is recognized as a typical anti-inflammatory cytokine related to the autoimmune disease, endotoxemia, liver inflammatory injury, obesity, and cancer [13] [14] [15] [16] [17] [18] . In the past decade, many investigators demonstrated the anti-inflammatory property of IL-37. IL-37 suppresses the production of various pro-inflammatory cytokines, including IL-1α , IL-1β , IL-6, IL-12, granulocyte colony-stimulating factor (G-SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and TNF-α . However, this property does not depend on the production of anti-inflammatory cytokines, such as IL -10 12 . IL-37 also inhibits activation of dendritic cells (DCs), thus playing a role in adaptive immunity 12, 19 . It has been documented that IL-37 forms an intracellular functional complex with Smad-3, relevant gene transcription is affected. Extracellular IL-37 binds to IL-18-binding protein (IL-18BP), and subsequently binds IL-18Rb, resulting in the inhibition of the pro-inflammatory activity of IL-18. In addition, IL-37 binds to the IL-18R a-chain, but with much lower affinity than that of IL-18 12, [20] [21] [22] . Because expression of IL-37 in the immune system keeps immune homeostasis, we supposed that IL-37 might be involved in the immune regulation processed by Tregs. The objective of this study was to identify IL-37expression in human CD4 + CD25
+
Tregs with Western blotting and confocal laser scanning microscopy, and further investigate the potential effect of IL-37 on Treg-mediated immunosuppression in vitro.
Results
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It is well known that Tregs are dull to mitogenic stimuli and inhibitors to T effect cell proliferation. Because CD4
Tregs could express IL-37, we further investigated whether IL-37 might be related to the regulation of Treg suppressive character. In this part of experiment, IL-37 gene was silenced by siRNA. Western blot analysis showed that IL-37 expression was markedly down regulated compared with the normal control in siRNA-IL-37 transfected CD4 +
+ Tregs ( (Fig. 7 ). However, IL-2 level in T cells was prominently elevated (P < 0.05) when IL-37expression was suppressed by siRNA in Tregs.
Discussion
IL-37 is the 7th factor (IL-1F7) of interleukin-1 family (IL-1F), and it is widely expressed in human organs and tissues. However, it does not exist in mouse for the lack of its locus 23 . Since the first report of IL-37 in 2000 24 , there has been many studies with regard to the anti-inflammatory effect of endogenous IL-37. Cysteinyl aspartate-specific protease (caspase)-1 processing is required for maturation of the intracellular IL-37 precursor and for the translocation of the cytokine to the nucleus 25 . In vitro, down-regulation of IL-37 in human peripheral blood mononuclear cells (PBMCs) increased the synthesis of various pro-inflammatory mediators, and it does not depend on the formation of anti-inflammatory cytokines such as IL-10. In vivo, injection of inflammatory cytokines towards transgenic for IL-37tg and control mice, the pro-inflammatory effect of the stimuli was markedly suppressed by IL-37b 12 . IL-37 expression in DCs not only promoted generation of semi-mature tolerogenic DCs, and it also suppressed antigen-specific immune response 19 . It has been demonstrated that Smad-3, a transcriptional modulator in TGF-β pathway, plays a significant role in the biological effects of IL-37b by contributing translocation of IL-37b to the nucleus 26 . A growing body of evidence indicates that IL-37 appears to be related to the autoimmune disease, endotoxemia, and liver inflammatory injury [13] [14] [15] [16] [17] [18] . It was revealed that IL-37 28, 29 , which was in accordance with our viewpoint in the current study. However, the potential significances and underlying mechanisms of IL-37 in mediating immune suppressive function of Tregs are poorly known. CD4 + CD25 + Tregs have been confirmed to perform main functions in processes of immune tolerance and regulation, including infection, inflammation/injury, tumor persistence/progression, and transplant tolerance [30] [31] [32] . Firstly, in the current study, it was noted that IL-37 maintained a weak expression in the + T cell differentiation as well as immunosuppression. It is well known that IL-37 is substantially expressed in human PBMCs and DCs, and it plays anti-inflammatory effects in maintaining immune homeostasis 12, 19 . Based on our own studies, demonstrating the presence of positive IL-37 expression in human CD4 + CD25 + Tregs, we speculated that IL-37 might play a regulatory role in immunosuppression of CD4 +
CD25
+ Tregs. It has been well known that CD4 + CD25 + Tregs exert immune suppressive activity through various mechanisms. As a particularly specific marker, the nuclear transcription factor FOXP3 is closely related to the development and function of Tregs. Mutation in FOXP3 gene could result in a maturity defection of Tregs and the performance of a deadly autoimmune disorder 6, 33 . We noticed that down-regulation of IL-37 markedly reduced FOXP3 level in CD4 +
+ Tregs, indicating that IL-37 might be an crucial factor in activating immunosuppression of CD4 + CD25 + Tregs. Similar to FOXP3, Tregs are enriched of CTLA-4 expression, which might be associated with lymphopenia-induced proliferation of CD4 + T cells 34 The results of present study showed that a down regulated expression of IL-37 could prominently lower CTLA-4 level on CD4 IL-10 and TGF-β are immune suppressive cytokines which are critically related to playing the tolerance speciality of Tregs 35 . In the present study, both IL-10 and TGF-β secreted levels, which measured in Furthermore, Tregs also prominently induced an immune homeostasis, including nonreactivity to the antigenic stimulation as well as the control of IL-2 formation and consumption of excessive IL-2 [34] [35] [36] . Because IL-2 generates indispensable stimulations for Tregs developed from thymus, we would like to know whether IL-37 could influence the production of IL-2. Our data showed that secreted levels of IL-2 in siRNA-IL-37 transfected CD4 + CD25 + Treg/CD4 + CD25 − T cell co-culture group were prominently rose, documenting that down-regulation of IL-37 level appears to be involved in the increase in Stimulated by different kinds of cytokines as well as co-stimulating molecules, CD4 + T cells can differentiate into groups of T cells, in terms of the levels of IFN-γ by Th1, and IL-4 as well as IL-10 by Th2 [37] [38] [39] [40] . Activated Tregs can mediate immunosuppressive effect by shifting the ratio of Th1/Th2, which leads to the signal activation of different T cell receptors. Herein we explored whether IL-37 expressed in CD4
Tregs had an impact on mediating drift of Th1/Th2. In the current experiment, the supernatants from co-culture cells were collected to analyze the quantities of cytokines generated from Th1 and Th2. It was interesting to notice that co-culture of CD4 Normal condition means that after being isolated from human PBMCs, Tregs were cultured with Treg expander for 24 h; si-RNA-IL-37 condition means that silenced Tregs were cultured with Treg expander for 24 h. The production of TGF-β and IL-10 was determined by ELISA. Results of independent experiments were shown as the mean ± SD. Statistically significant difference when compared with normal controls, *P < 0.05. In conclusion, the present study in vitro demonstrates that IL-37 expression in human CD4 + CD25 + Treg can promote the suppressive effect on T lymphocyte activation. An understanding of the key role of IL-37 in the immunosuppressive activity of human CD4 +
+ Tregs may expand our view for further research regarding immune homeostasis and immune related diseases. Nevertheless, more investigation is required to study the precise mechanism underlying IL-37 on CD4 + CD25 + Tregs including intracellular as well as extracellular functions and the potential effect associated with host immune response in vivo.
Materials and Methods
This study was conducted according to the principles expressed in the Declaration of Helsinki. The manuscript statements of informed consent were obtained from all blood donors. This study was approved by the Ethics Committee and Scientific Investigation Board of the Chinese People's Liberation Army 309th Hospital, Beijing, China.
Blood samples. 15 
CD25
+ Tregs (> 93%). Trypan blue was used to identify the cellular activity.
Immunoblotting and confocal microscopy analysis. Immunoblotting and confocal microscopy analysis were used to analysis the expression of IL-37 in human CD4 + CD25 + Tregs. Tregs were resuspended in lysis buffer which contained protease inhibitor mixture. Then cells were centrifuged at 10,000 × g for 15 min at 4 °C. samples were added on 10% SDS gels, and then, gels were electro-transferred to an immobilonpolyvinylidene difluoride membrane. Blocking with milk overnight on ice, the membrane was incubated with anti-37 polyclonal Ab (Abcam, Cambridge, UK) (1:500) for 4 h at room temperature or anti-β -actin as control group. Membrane incubated with peroxidase-labelled affinity secondary Ab for 1 h after washed three times. Then, the membrane was processed by a ECL plus chemiluminescence kit (Amersham Biosciences, Uppsala, Sweden). In the process of confocal microscopy analysis, CD4 +
+ Tregs were activated for 48 h, and then, cells were fixed with 4% paraformaldehyde in PBS for 20 min. After being permeabilized with 0.02% Triton X-100 for 20 min at room temperature, the cells were blocked with bovine serum albumin for 30 min and incubated with anti-IL-37 polyclonal Ab (Abcam, Cambridge, UK) (1:200) overnight at 4 °C. After being stained with goat FITC-anti-IgG as the second Ab for 1 h at room temperature, samples were observed with a laser scanning confocal microscope (Leica, Mannheim, Germany).
RNA interference. Small interference RNA (siRNA) of IL-37 was obtained from Thermo Fisher Scientific Co. 12 . This kind of 100 nM siIL-37 targeted all isoforms of IL-37, comprised 25 nM of the four following antisense sequences: I, 5′ -UCAAGGAUGAGGCUAAUGCUU-3′ ; II, 5′ -CAAUGUGUUUCCUGUUCUCUU-3′ ; III, 5′ -UUACAAUUGCAGGAGGUGCUU-3′ ; IV, 5′ -UUAUCCUUGUCACAGUAGAUU-3′ . Electroporation was performed by Amaxa device. After overnight recovery, CD4 + CD25 + Tregs were co-cultured with siIL-37 for 72 h to knock-down IL-37 expression. Concomitantly, the same number of control siRNA as wild type control was transfected. The efficiency of knock-down was measured by immunoblotting. In this part experiment, we found that the Treg cells survival rate declined obviously. And about 30% cells dead after being silenced by IL-37-siRNA or scramble-siRNA. So we removed the dead cells and collected living cells for next experiment. Trypan blue was used to identify the cellular activity.
Cell stimulation and suppression assay in vitro. Human CD4 + CD25 − T cells and CD4 + CD25 + Tregs were co-cultured in 96-well culture plate (1:1 ratio). These cells were stimulated with a combination of 1 μ g/ml of soluble anti-CD3 and anti-CD28 monoclonal Abs (BD Biosciences, Mountain View, CA) at 37 °C and 5% CO 2 for 72 h. Thereafter, modified3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (5 mg/ml, 10 μ l/well) 23, [41] [42] [43] was added in each sample and the incubation continued for 4 h. The suspending crystals were blown by pipette repeatedly, then optical density of samples were separately measured by microplate reader under the wave length of 540 nm. These experiments were repeated three times and results were the mean of three samples. Statistics analysis. Quantitative values, with the respective experiment repeated triplicate, were expressed as the mean ± standard deviation (SD). A paired two-tailed Student t test was performed in cases. The differences between multiple groups were analyzed by one-way ANOVA. The p-value less than or equal to 0.05 was considered significant.
Flow cytometric analysis. Fluorescein isothiocyanate (FITC)
-
